Chemotherapy Induced Nausea and Vomiting – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Chemotherapy Induced Nausea and Vomiting – Drugs In Development, 2024 report and make more profitable business decisions.
Chemotherapy-induced nausea and vomiting (CINV) is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Other symptoms include a rapid heart rate, sweating, dizziness, and increased saliva. Risk factors include age, drug, dose, and the schedule and route of the drug’s administration.
The Chemotherapy Induced Nausea and Vomiting drugs in development market research report provide comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Chemotherapy Induced Nausea and Vomiting | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 29 molecules, with 29 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Chemotherapy Induced Nausea and Vomiting therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Chemotherapy Induced Nausea and Vomiting pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Chemotherapy Induced Nausea and Vomiting treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Acacia Pharma LtdAcuCort AB
Amzell BV
Aphios Corp
Arovella Therapeutics Ltd
Benuvia Therapeutics Inc
Bionorica SE
Camurus AB
Daewoong Pharmaceutical Co Ltd
Ethicann Pharmaceuticals Inc
Formulex Pharma Innovations Ltd
Helsinn Healthcare SA
Hoverink Biotechnologies Inc
Incannex Healthcare Ltd
IntelGenx Corp
iX Biopharma Ltd
Jiangsu Hengrui Medicine Co Ltd
LipoSeuticals Inc
LP Pharmaceutical (Xiamen) Co Ltd
Luxena Pharmaceuticals Inc
RedHill Biopharma Ltd
Senzer Ltd
Shackelford Pharma Inc
Starton Therapeutics Inc
Zhuhai Beihai Biotech Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Chemotherapy Induced Nausea and Vomiting reports